Bacteremia: Clinical Diagnostics and Epidemiology
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: closed (15 August 2024) | Viewed by 6112
Special Issue Editor
Special Issue Information
Dear Colleagues,
Bacteremia incurs a high burden of disease globally. It is a major cause of morbidity and mortality in both hospital and community settings. Old age and comorbidities, i.e., malignancy, end-organ disease, and diabetes mellitus, continue to place an individual at excess risk for bacteremia. During the COVID-19 pandemic, there was a relative increase in primary and respiratory disease-related bacteremia in addition to hospital-acquired bacteremia. COVID-19 has significantly changed the epidemiology of bacteremia, with primary and hospital-acquired BSI being more common in patients with SARS-CoV-2 infection. Advances in microbiological techniques have led to improvements in the laboratory processing of blood culture specimens, reducing turnaround time, and increasing the speed of diagnosis of bacteremia. The increasing use of rapid molecular tests which identify the culprit pathogen and relevant antimicrobial resistance genes within hours also may be improving patient care in the modern era. Other contemporary diagnostic platforms can provide antimicrobial susceptibility results from blood culture samples in a fraction of the time, thereby shifting the treatment of bacteremia earlier toward more narrow-spectrum therapy. This Special Issue seeks manuscript submissions that further our understanding of the epidemiology and microbiological diagnosis of bacteremia. Submissions on novel rapid diagnostics and updates regarding the prevention of bacteremia are especially encouraged.
Dr. Adam G. Stewart
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bacteremia
- bloodstream infection
- epidemiology
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.